Nanobiotix (NBTX) Current Assets (2018 - 2025)

Nanobiotix's Current Assets history runs 8 years deep, the most recent figure standing at $73.0 million for Q4 2025.

• On a quarterly basis, Current Assets rose 11.21% year-over-year to $73.0 million in Q4 2025; TTM through Dec 2025 was $73.0 million, a 11.21% increase from a year earlier, with the FY2025 full-year figure at $70.9 million, up 7.94% from the prior year.
• Current Assets grew to $73.0 million in Q4 2025 per NBTX's latest filing, from $45.2 million in the prior quarter.
• Across five years, Current Assets topped out at $139.5 million in Q2 2021 and bottomed at $36.6 million in Q2 2023.
• The 5-year median for Current Assets is $75.4 million (2022), against an average of $77.8 million.
• Across the five-year window, Current Assets sank 52.9% in 2023 and surged 136.61% in 2024, its largest moves.
• Year by year, Current Assets stood at $106.5 million in 2021, then slumped by 49.82% to $53.4 million in 2022, then soared by 75.92% to $94.0 million in 2023, then sank by 30.1% to $65.7 million in 2024, then gained by 11.21% to $73.0 million in 2025.
• Per Business Quant, the three latest NBTX Current Assets figures stand at $73.0 million (Q4 2025), $45.2 million (Q2 2025), and $65.7 million (Q4 2024).